Post by Capital Group

Innovation isn't exclusive to Big Tech. In the healthcare sector, drug makers are accelerating R&D efforts and developing new therapies and treatment protocols that may lead to stronger outcomes, for patients and investors. Free cash flow further supports advancement as deep pipelines reduce reliance on any single product. Swipe to see where pharma companies are focused and how this powerful combination could translate to long-term portfolio returns. #CapGroupGlobal